
Analysis of Sarepta Therapeutics (SRPT) options reveals potential strategies for investors. Selling a $37 put offers a net cost basis of $34.65 with a 57% chance of expiring worthless, yielding a 6.35% return (46.36% annualized). Alternatively, a covered call strategy selling the $38 call generates an 8.19% return if the stock is called away, with a 46% chance of the contract expiring worthless, resulting in a 6.43% yield boost (46.92% annualized); implied volatility for the put and call options are 78% and 83% respectively, while the trailing twelve month volatility is 73%.
Sarepta Therapeutics (SRPT), currently trading at $37.34 per share, presents distinct options trading opportunities. Selling the $37.00 strike put contract, with a bid of $2.35, offers an effective cost basis of $34.65 if assigned, representing a potential discount. There is a 57% statistical probability of this put expiring worthless, which would result in a 6.35% return on the cash commitment, or an annualized YieldBoost of 46.36%. Alternatively, a covered call strategy involving purchasing SRPT shares at $37.34 and selling the $38.00 strike call option (bid at $2.40) could yield a total return of 8.19% if the stock is called away by the August 1st expiration. The probability of this call expiring worthless is 46%, in which case the premium would provide a 6.43% YieldBoost, equating to 46.92% annualized. Notably, the implied volatility for the put option is 78% and for the call option is 83%, both exceeding SRPT's actual trailing twelve-month historical volatility of 73%, suggesting that option premiums are currently elevated relative to past price movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment